Biotech Stocks


Juno Therapeutics Inc (JUNO) to Make Key Presentations; Shares Soar

Juno Therapeutics Inc (NASDAQ:JUNO) shares gained 9% after the company said it will present updated clinical and preclinical results from the company and …

Company Update (NASDAQ:ICPT): Intercept Pharmaceuticals Inc Announces 3Q:17 Financial Results and Provides Business Update

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) reported financial results for the three months ended September 30, 2017, and provided other general business updates. “We are …

Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces 3Q:17 Financial Results and Provides Update on Operations

Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced financial results for the three and nine months ended September 30, 2017, and provided an update on company …

Derek Archila Worries Insys Therapeutics Inc (INSY) Faces a Poor Set-Up Amid Legal Scandal

INSY’s whopper of a lawsuit has Oppenheimer sounding off with a note of caution.

Transenterix Inc (TRXC) Earns a Price Target Jump, EXACT Sciences Corporation (EXAS) Business Poised to Take Off Within 3 Years

Rick Wise: High surgeon intrigue in TRXC’s Senhance; Mark Massaro: EXAS could hit 2.7M in tests by 2021.

Valeant Pharmaceuticals Intl Inc (VRX) Looks To Pay Down $125M In Debt; Louise Chen Bullish

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced today that it will pay down $125 million of senior secured loans, keeping it on track with …

Court Rules in Favor of Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Patent Infringement Suit on Uceris

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced that the United States District Court for the District of Delaware has ruled in the Company’s favor in …

Maxim Reiterates Buy On ContraVir Pharmaceuticals Inc (CTRV) Following Corporate Update

Maxim analyst Jason Kolbert is out today with a new research note on shares of ContraVir Pharmaceuticals Inc (NASDAQ:CTRV), following the company’s third-quarter results and …

H.C. Wainwright Gets More Confident On Aurinia Pharmaceuticals Inc (AUPH); Here’s Why

Ed Arce lifts his price target on AUPH after recent R&D day widened doors to voclosporin’s opportunity.

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Gets a Price Target Cut Ahead of Q3 Results

Irina Rivkind Koffler worries that the Copaxone generics competitive backdrop threatens TEVA immensely.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts